Quote | Novamind Inc. (OTCMKTS:NVMDF)
Last: | $0.27 |
---|---|
Change Percent: | 35.0% |
Open: | $0.22295 |
Close: | $0.27 |
High: | $0.27 |
Low: | $0.2049 |
Volume: | 8,935 |
Last Trade Date Time: | 06/13/2022 04:37:32 am |
News | Novamind Inc. (OTCMKTS:NVMDF)
The pressure is ramping up on the U.S. Drug Enforcement Administration (DEA) as more lawyers, clinicians, researchers, investors and business owners working in the psychedelics industry are demanding clear answers about how the DEA should be evolving on its drug scheduling and e...
TORONTO, ON / ACCESSWIRE / June 10, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announced today that the Company has completed its previously announced acquisition by Numinus Welln...
Message Board Posts | Novamind Inc. (OTCMKTS:NVMDF)
Subject | By | Source | When |
---|---|---|---|
$NVMDF: Novamind Inc has announced that the Company | Renee | investorshub | 06/13/2022 9:09:53 PM |
Huge: Novamind to Host MindMed Phase IIb Trial | PyroStocks | investorshub | 03/16/2022 7:01:00 PM |
Hinterland Metals Inc., HNLMF, changed to Novamind Inc., NVMDF: | Renee | investorshub | 02/19/2021 1:21:14 AM |
News: $HMI Huami Corporation Announced Corporate Mission: Connect | whytestocks | investorshub | 12/05/2019 4:00:14 AM |
News: $HMI Huami Corporation to Hold 2019 Annual | whytestocks | investorshub | 11/28/2019 12:30:18 PM |
News, Short Squeeze, Breakout and More Instantly...
Novamind Inc. Company Name:
NVMDF Stock Symbol:
OTCMKTS Market:
The pressure is ramping up on the U.S. Drug Enforcement Administration (DEA) as more lawyers, clinicians, researchers, investors and business owners working in the psychedelics industry are demanding clear answers about how the DEA should be evolving on its drug scheduling and e...
TORONTO, ON / ACCESSWIRE / June 10, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announced today that the Company has completed its previously announced acquisition by Numinus Welln...
Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws. Numinus shareholders, at a separate meeting held today, have also approved the resolutions related t...